| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Chester Beatty Research Institute, Institute of Cancer Research, Royal Cancer Hospital, Fulham Road, London, SW3 6JB [A. D., L. S. L.], and Paterson Laboratories, Christie Hospital and Holt Radium Institute, Manchester M20 9BX, England [P. T. I.]
5,6-Dihydro-5-oxo-7,12-dimethylbenz[a]anthracene and 5,6-dihydro-6-oxo-7,12-dimethylbenz[a]anthracene are described. These compounds, which are isomeric with 7,12-dimethylbenz[a]anthracene-5,6-oxide (the K-region epoxide), were inactive in tests for tumor-initiating activity in mouse skin and tumor production in the s.c. tissue of the mouse.
1 This work was supported by grants to the Chester Beatty Research Institute and the Paterson Laboratories from the Medical Research Council and the Cancer Research Campaign.
Received 9/16/74. Accepted 12/ 6/74.
This article has been cited by other articles:
![]() |
M. A. Pereira Mouse Skin Bioassay for Chemical Carcinogens International Journal of Toxicology, January 1, 1982; 1(1): 47 - 82. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |